BriaCell Therapeutics Corp. Liquidation Value Calculator
BriaCell Therapeutics Corp.
Current Price: N/A
Loading calculator data...
Advanced: All 63 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$29.90M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$29.90M | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$3.19M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
7.3M | shares | ||
Unmapped Tags (57)
| Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent | $1.31M | USD | ||
| Accounts Payable Trade Current AccountsPayableTradeCurrent | $1.88M | USD | ||
| Assets Assets | $33.59M | USD | ||
| Assets Current AssetsCurrent | $32.18M | USD | ||
| Assets Fair Value Disclosure AssetsFairValueDisclosure | $29.90M | USD | ||
| Assets Noncurrent AssetsNoncurrent | $1.42M | USD | ||
| Common Stock No Par Value CommonStockNoParValue | $0 | USD/shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $7.25M | shares | ||
| Common Stock Value CommonStockValue | $117.12M | USD | ||
| Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent | $195,096 | USD | ||
| Equity Securities FVNI Noncurrent EquitySecuritiesFVNINoncurrent | $582,455 | USD | ||
| Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill | $176,889 | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $243,607 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $33.59M | USD | ||
| Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure | $195,096 | USD | ||
| Liabilities Noncurrent LiabilitiesNoncurrent | $195,096 | USD | ||
| Minority Interest MinorityInterest | $-702,631 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $251,141 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-127.17M | USD | ||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | $30.21M | USD | ||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | $580,542 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $19.41M | USD | ||
| Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable | $-1.40M | USD | ||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | $611,618 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $27.87M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $7.21M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-15.67M | USD | ||
| Payments To Acquire Investments PaymentsToAcquireInvestments | $165,000 | USD | ||
| Proceeds From Grantors ProceedsFromGrantors | $826,158 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $27.87M | USD | ||
| Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity | $30.00M | USD | ||
| Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments | $7.37M | USD | ||
| Share Based Compensation ShareBasedCompensation | $580,542 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | $0 | pure | ||
| Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | $22,676 | shares | ||
| Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | $50,951 | shares | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax | $-138,684 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-3 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-7 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $3.12M | USD | ||
| Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments | $-106,823 | USD | ||
| Net Income Loss NetIncomeLoss | $-15.42M | USD | ||
| Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest | $-155,836 | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $243,235 | USD | ||
| Operating Expenses OperatingExpenses | $15.85M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-15.85M | USD | ||
| Prepaid Expense Noncurrent PrepaidExpenseNoncurrent | $405,085 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $12.74M | USD | ||
| Adjustment For Amortization AdjustmentForAmortization | $7,636 | USD | ||
| Depreciation Depreciation | $45,678 | USD | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-142,576 | USD | ||
| Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax | $-372 | USD | ||
| Profit Loss ProfitLoss | $-15.58M | USD | ||
| Share Price SharePrice | $4 | USD/shares | ||
| Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised | $132,000 | shares | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $27.87M | USD | ||
| Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised | $165,000 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.